Get started
Award

UM1 CA164920

Funded outputs count: 53
Funder award ID: UM1 CA164920
OpenAlex ID: G3851761820
PRANA: A Deep Learning Method for Adapting Polygenic Risk Scores to Diverse Ethnic Groups
2026 · Hagai Levi, Qin Wang, et al. · medRxiv
PDF
Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies
2024 · Olshan, A.F., Jung, A.Y, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
2024 · Castelao, J.E., Geisler, J., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Combined Associations of a Polygenic Risk Score and Classical Risk Factors with Breast Cancer Risk
2024 · Mavaddat, N., Schoemaker, M.J., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
2024 · Koutros, S., Janni, W., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
2024 · Manoukian, S., Ramachandran, D., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2
2023 · Maria Zanti, Denise G. O'Mahony, et al. · Human Mutation · 6
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
2023 · Pooja Middha, Xiaoliang Wang, et al. · Breast Cancer Research · 14
PDF
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
2023 · Hagai Levi, Shai Carmi, et al. · Journal of Medical Genetics · 4
PDF
Association of the CHEK2 c. 1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival
2023 · Anna Morra, Maartje A. C. Schreurs, et al. · Cancer Medicine · 11
PDF
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
2023 · Denise G. O’Mahony, Susan J. Ramus, et al. · British Journal of Cancer · 21
PDF
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry
2023 · Stefanie H. Mueller, Alvina G. Lai, et al. · Genome Medicine · 15
PDF
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival
2023 · Josephine M.N. Lopes Cardozo, Irene L. Andrulis, et al. · Journal of Clinical Oncology · 28
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
2022 · Christopher Hakkaart, John F. Pearson, et al. · Communications Biology · 14
PDF
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
2022 · Suzanne C Dixon-Suen, Sarah J Lewis, et al. · British Journal of Sports Medicine · 87
Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies
2022 · Audrey Y Jung, Thomas U Ahearn, et al. · JNCI Journal of the National Cancer Institute · 48
PDF
Rare germline copy number variants (CNVs) and breast cancer risk
2022 · Joe Dennis, Jonathan P. Tyrer, et al. · Communications Biology · 15
PDF
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
2021 · Maria Escala-Garcia, Sander Canisius, et al. · Scientific Reports · 5
PDF
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
2021 · Anna Morra, Maria Escala-Garcia, et al. · Breast Cancer Research · 22
PDF
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.
2021 · Morra, Anna, Escala-Garcia, Maria, et al. · Apollo (University of Cambridge)
PDF
Mendelian randomisation study of smoking exposure in relation to breast cancer risk
2021 · Hanla A. Park, Sonja Neumeyer, et al. · British Journal of Cancer · 22
PDF
Breast and Prostate Cancer Risks for MaleBRCA1andBRCA2Pathogenic Variant Carriers Using Polygenic Risk Scores
2021 · Daniel R Barnes, Valentina Silvestri, et al. · JNCI Journal of the National Cancer Institute · 45
PDF
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
2021 · Juliette Coignard, Michael Lush, et al. · Nature Communications · 40
PDF
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
2021 · NBCS Collaborators, Nichola Johnson, et al. · British Journal of Cancer · 9
Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium
2021 · Anna Morra, Audrey Y. Jung, et al. · Cancer Epidemiology Biomarkers & Prevention · 38
PDF
Year
Topic